JPML Won't Centralize Gerber Baby Formula Suits

Law360, New York (October 16, 2012, 7:05 PM EDT) -- The Judicial Panel on Multidistrict Litigation on Tuesday refused to centralize in New Jersey 10 proposed class actions claiming Gerber Products Co. baby formula containing probiotics is not as healthy as marketed, saying pending transfer motions could make centralization moot.

In denying the motion, the panel said five of the 10 actions are already located in New Jersey, where Gerber is headquartered, and in all the non-New Jersey actions, pending motions seeking a transfer of litigation under Section 1404 of the U.S. Code could make centralization...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.